Recurring pathogenic variants in the BRCA2 gene in the Ethiopian Jewish population. Founder mutations? Mark D. LudmanShira Litz PhilipsbornEyal Reinstein Letter to the Editor 15 February 2022 Pages: 121 - 123
Questioning the validity of clinically available breast cancer polygenic risk scores: comparison of two labs reveals discrepancies Julia WynnElana LevinsonWendy K. Chung Letter to the Editor 18 May 2021 Pages: 125 - 127
Extended gene panel testing in lobular breast cancer Elke M. van VeenD. Gareth EvansMiriam J. Smith Original Article Open access 25 March 2021 Pages: 129 - 136
A comprehensive reference for BRCA1/2 genes pathogenic variants in Iran: published, unpublished and novel Keivan Majidzadeh-AShiva ZarinfamMohamad Zamani Original Article 23 March 2021 Pages: 137 - 142
“I wish that there was more info”: characterizing the uncertainty experienced by carriers of pathogenic ATM and/or CHEK2 variants Kathryn G. ReyesCheyla ClarkKelly E. Ormond Original Article 15 April 2021 Pages: 143 - 155
Pilot study of an online training program to increase genetic literacy and communication skills in oncology healthcare professionals discussing BRCA1/2 genetic testing with breast and ovarian cancer patients Bettina MeiserPaula WoodwardKathy Tucker Original Article 10 May 2021 Pages: 157 - 166
Adaptation and early implementation of the PREdiction model for gene mutations (PREMM5™) for lynch syndrome risk assessment in a diverse population Kathleen F. MittendorfChinedu UkaegbuKatrina A. B. Goddard Original Article Open access 23 March 2021 Pages: 167 - 180
A novel founder MSH2 deletion in Ethiopian Jews is mainly associated with early-onset colorectal cancer I. KedarL. WalshY. Goldberg Original Article 10 April 2021 Pages: 181 - 188
Malignancy risk in individuals with familial adenomatous polyposis receiving biologics and immunomodulators Muhammad Salman FaisalCarol A. BurkeGautam Mankaney Original Article 06 April 2021 Pages: 189 - 195
The clinical features of polymerase proof-reading associated polyposis (PPAP) and recommendations for patient management Claire PallesLynn MartinAndrew Latchford Original Article Open access 05 May 2021 Pages: 197 - 209
First international workshop of the ATM and cancer risk group (4-5 December 2019) Fabienne LesueurDouglas F. EastonNadine Andrieu Review 14 June 2021 Pages: 211 - 227
Von Hippel-Lindau disease and rapidly progressing pheochromocytomas in siblings Ioana FugaruCatherine GoudieJohn-Paul Capolicchio Short Communication 20 April 2021 Pages: 229 - 233
CDH1 pathogenic variants and cancer risk in an unselected patient population Ariel Bar-MashiahEmily R. SoperNoura S. Abul-Husn Short Communication 22 April 2021 Pages: 235 - 239
The psychological impact and experience of breast cancer screening in young women with an increased risk of breast cancer due to neurofibromatosis type 1 Ashley CrookRebekah KwaYemima Berman Original Article 08 May 2021 Pages: 241 - 253